Contagious caprine pleuropneumonia – a comprehensive review. Issue 1 (1st January 2019)

• Record Type: Journal Article
• Authors: Iqbal Yatoo, Mohd.; Raffiq Parray, Oveas; Tauseef Bashir, Shah; , Muheet; Ahmed Bhat, Riyaz; Gopalakrishnan, Arumugam; Karthik, Kumaragurubaran; Dhama, Kuldeep; Vir Singh, Shoor
• Is Part Of: Veterinary quarterly. Volume 39:Issue 1(2019)
• Page Start: 1
• Page End: 25
• Publication Date: 2019-01-01
• Subjects: Goat -- caprine -- pleuropneumonia -- Mycoplasma -- vaccine; Veterinary medicine -- Periodicals; Veterinary Medicine; Veterinary medicine -- Periodicals; Veterinary research -- Periodicals; Veterinary medicine; Periodicals; Periodicals; 636.089
• DOI: 10.1080/01652176.2019.1580826
• Languages: English
• ISSNs: 0165-2176

Abstract

Abstract: Contagious caprine pleuropneumonia (CCPP) is a serious disease of goats, occasionally sheep and wild ruminants, caused by Mycoplasma capricolum subspecies capripneumoniae (Mccp). The disease is characterized by severe serofibrinous pleuropneumonia, very high morbidity (∼100%), and mortality (80–100%). CCPP affects goats in more than 40 countries of the world thereby posing a serious threat to goat farming around the globe. The characteristic clinical signs of CCPP are severe respiratory distress associated with sero-mucoid nasal discharge, coughing, dyspnea, pyrexia, pleurodynia, and general malaise. In later stages, severe lobar fibrinous pleuropneumonia, profuse fluid accumulation in pleural cavity, severe congestion of lungs and adhesion formation is observed. Mycoplasmal antigen interactions with host immune system and its role in CCPP pathogenesis are not clearly understood. CCPP is not a zoonotic disease. Diagnosis has overcome cumbersome and lengthy conventional tests involving culture, isolation, and identification by advanced serological (LAT, cELISA) or gene-based amplification of DNA (PCR, RFLP, and hybridization) and sequencing. The latex agglutination test (LAT) is rapid, simple, and better test for field and real-time diagnosis applicable to whole blood or serum and is more sensitive than the CFT and easier than the cELISA. Moreover, the studies on antibiotic sensitivity and exploration of novel antibiotics (fluoroquinolones, macrolides) can help in better therapeutic management besides preventing menace of antibiotic resistance. Re-visiting conventional prophylactic measures focussing on developing novel strain-based or recombinant vaccines using specific antigens (capsular or cellular) should be the most important strategy for controlling the disease worldwide.